<html><body><h2>Case: 1234</h2>
<hr>
<h2>Guideline Manager Output </h2>
<bold>Patient classification:</bold> <ul>
<li>JNC-VI Hypertension Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(presence of diagnosis of hypertension && no diagnosis of pregnancy && Absense of Secondary Hypertension && absence of spinal cord injury && absence of narcolepsy && Not taking cyclosporine && Not taking spironolactone && Not taking minoxidil && absence of renovascular disease && absence of IHSS && Absence of Ascites && Not off guideline && Age(83.0/2008-6-4) && Antihypertensive_Agents && not taking tacrolimus && absence of transplant recipient && eGFR(90.0/2006-1-1) && Absence of a dialysis procedure code)</i>]
</ul>
<bold>Scenario choice:</bold> on two or three anti-hypertensive drugs
<p>
<bold>Goal:</bold> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><bold>Reached goal?</bold> failed(Treatment_Diastolic_BP(93/MD_Typical_Diastolic_BP))
<hr>
<bold>Action Choices</bold>
<ul>
<li><b>on medication: things to check</b><br>
<ul>
<li><b>assumption no dx hypertension  <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
If this patient does not have hypertension, or if this patient already has a diagnosis of secondary hypertension on the problem list, please take a moment to tell us that, using the "comment" box at the bottom of the recommendations screen.  You can also send us an email, if you like, in DHCP (VA Palo Alto): Susana Martins (Susana.Martins@med.va). You can open DHCP to send email without closing your CPRS-GUI window.
<li><b>assumption exclusion <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
This program does NOT provide recommendations for patients with SECONDARY HYPERTENSION, NARCOLEPSY, ASCITES, SPINAL-CORD INJURY , or IDIOPATHIC HYPERTHROPHIC SUBAORTIC STENOSIS. If this patient has one or more of these diagnoses, please ADD it to the patient's PROBLEM LIST.
<li><b>assumption Update BP, on meds <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
A BP entered into the ATHENA system today will not be entered into the patient's electronic medical record.  The program will use the BP to update the recommendations on the screen, but it will not write the BP to VistA, so the BP will not show up in   CPRS-GUI.  You can enter additional BP's into the patient's permanent medical record by clicking 'BP' in the Vitals box on the CPRS-GUI main screen.  Click 'Enter Vitals' in the top left of the screen, select the appropriate appointment location, and then enter the new blood pressure at the prompt.  Any BP you add to the patient's medical record today will be available to this program at the patient's next visit. The ATHENA system will have a write-back feature implemented in the near future that will allow you to write BP's you enter in ATHENA to CPRS.
<li><b>assumption disclaimer about procedure reports <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
Diagnoses from procedure reports (EKG, X-ray, etc.) are not recognizable to ATHENA DSS.  ATHENA pulls diagnoses from the problem list and the list of diagnoses for each visit on the encounter forms.  The Patient Summary in ATHENA shows the diagnoses for this patient that are known to the program. If patient has a diagnosis that is not included in the Patient Summary, please update the problem list, or include the diagnosis on today's encounter form.
<li><b>assumption Disclaimer, on meds <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
Recommendations of the ATHENA DSS must be considered in the context of full information about the patient and the clinician-patient interaction.  The final responsibility for medical management rests with the prescribing/treating clinician (physician or nurse practitioner).  While we have made every effort to ensure that the recommendations generated by ATHENA DSS reflect the current evidence for management of hypertension, we cannot guarantee that the program will generate a recommendation for the best treatment in all cases.  Please use your clinical judgment in evaluating recommendations from ATHENA DSS.  If you see recommendations that you believe represent errors in the program, please call them to our attention.
<li><b>Assumption drug dosage <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
Daily dosage calculation is based on the following formula:  [(strength of dosage form) x (number of dosage forms)]/days supply. If extra dosage forms (tablets) are dispensed there may be an overestimation of actual daily dose.  The calculated daily dose is displayed in the patient summary.
<li><b>assumption about prescriptions <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
If a prescription expires, it will not appear on the active medication list though the patient may still be taking the medication.  This will be reflected correctly in the prescription graph (see BP-Prescription Graphs tab).  
<li><b>ADR to drug with active prescription <font color=FF0000>preferred</font></b>(rule in criterion<i> Taking 1 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
<li><b>adverse event warning <font color=FF0000>preferred</font></b>(rule in criterion<i> presence of current medication with adverse reaction</i> evaluate to <b> true</b> because <i>presence of current medication with adverse reaction</i>)])
<li><b>Combination therapy <font color=FF0000>preferred</font></b>(rule in criterion<i> taking 2 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
There is not much information on combination therapy for hypertension. If BP is not controlled after 3 months at maximum tolerated dose we suggest substituting one or more drugs.
<li><b>on hctz <font color=FF0000>preferred</font></b>(rule in criterion<i> HCTZ<=25mg and Cr<=2.0</i> evaluate to <b> true</b> because <i>HCTZ >25mg && Creatinine(1.4/2006-1-2) && presence of thiazide diuretics</i>)])
HCTZ dose above 25 mg doesn't add to BP control for most patients and may lead to hypokalemia.
<li><b>Assumptions <font color=FF0000>preferred</font></b>(rule in criterion<i> presence of diagnosis of hypertension</i> evaluate to <b> true</b> because <i>presence of diagnosis of hypertension</i>)])
The eGFR is calculated based on the most recent serum creatinine.
<li><b>test parameterized message <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</b> because <i></i>)])
It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: lisinopril, hydrochlorothiazide
<li><b>Orthostatic hypotension risk <font color=FF0000>preferred</font></b>(rule in criterion<i> postural hypotension risk</i> evaluate to <b> true</b> because <i>presence of HCTZ</i>)])
Patients with Active prescription for thiazide, Age > 65 are at higher risk of postural hypotension. Check orthostatic BP.
<li><b>Disclaimer <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</b> because <i></i>)])
The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
<li><b>On 2 meds from the same class <font color=FF0000>preferred</font></b>(rule in criterion<i> taking 2 or more antihypertensive agents</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
</ul>
<li><b>two or three drug-therapy choices</b><br>
<ul>
<li><b>Blood pressure not adequately controlled. Intensify drug treatment <font color=FF0000>preferred</font></b>(strict rule-in condition<i> BP not adequately controlled based on most recent BP</i> evaluate to <b> true</b> because <i>BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(93/MD_Typical_Diastolic_BP)</i>)])
Consider INTENSIFYING drug treatment: BP ELEVATED based on most recent available BP; F/up 1month.
</ul>
<li><b>step up choices</b><br>
<ul>
<li><b>evaluate increasing dose (no MI, verapamil/diltz) <font color=FF0000>preferred</font></b>(strict rule-in condition<i> there exists non-contraindicated drug not at maximum dose</i> evaluate to <b> true</b> because <i>there exists non-contraindicated drug not at maximum dose</i>)])

<li><b>evaluate new drug to prescribe <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</b> because <i></i>)])

</ul>
<li><b>addition considerations</b><br>
<ul>
</ul>
<li><b>Final recommendations</b><br>
<ul>
</ul>
<li><b>increase dose considerations</b><br>
<ul>
<li><b>Multiple Dosing Increases <font color=FF0000>preferred</font></b>(rule in criterion<i> Multiple Dose Increase</i> evaluate to <b> true</b> because <i>Antihypertensive_Agents</i>)])
When modifying the dosage of multiple drugs, doses should be carefully titrated one medication at a time to minimize the potential of dose related adverse events.
</ul>
<li><b>Final recommendations</b><br>
<ul>
</ul>
</ul>
<hr>
<bold>If changing attribute, consider: </bold><ul>
<li>lisinopril(change drug_daily_dose: up to High_Dose)

<li>hydrochlorothiazide(change drug_daily_dose: up to Medium_Dose)

</ul>
<bold>Considerations for adding drug: </bold><ul>
<li>DHP Calcium Channel Blocker (felodipine, nifedipine SA)
<ul>
<li>preference: neutral
<li>No comment
</ul>
<li>(non-DHP) Calcium Channel Blocker (diltiazem)
<ul>
<li>preference: neutral
<li>No comment
</ul>
<li>Alpha Blocker (terazosin)
<ul>
<li>preference: neutral
<li>No comment
</ul>
<li>Cardioselective Beta Blocker (atenolol)
<ul>
<li>Drugs to partner:  Thiazide_Diuretics(hydrochlorothiazide) 
<li>Relative contraindications:  Bronchospastic_Disease(493.00) 
<li>preference: neutral
</ul>
<li>Potassium Sparing Diuretic 
<ul>
<li>Relative contraindications:  Renal_Insufficiency(584.9) 
<li>preference: neutral
</ul>
<li>Angiotensin II Receptor Blocker (irbesartan)
<ul>
<li>Drugs with bad interactions:  ACE_Inhibitors(lisinopril) 
<li>preference: ruled out
</ul>
<li>Thiazide Diuretic (HCTZ)
<ul>
<li>Already being used
<li><font color=FF0000>Compelling indications:  taking >= 2 anti hypertensive meds(Combination therapy for HTN[Antihypertensive_Agents]) </font>
<li>preference: ruled out
</ul>
<li>ACE Inhibitors(lisinopril)
<ul>
<li>Already being used
<li>preference: ruled out
</ul>
</ul>
<hr>
83.0 year old Black_Non-Hispanic Male
<p><b>Labs:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">83</td><td width="200">2008-6-4</td></tr>
<tr><td width="200">eGFR</td><td width="200">90</td><td width="200">2006-1-1</td></tr>
<tr><td width="200">BMI</td><td width="200">29</td><td width="200">2006-1-1</td></tr>
<tr><td width="200">DB_Systolic_BP</td><td width="200">150</td><td width="200">2006-1-1</td></tr>
<tr><td width="200">DB_Diastolic_BP</td><td width="200">90</td><td width="200">2006-1-1</td></tr>
<tr><td width="200">Sodium</td><td width="200">135</td><td width="200">2006-1-2</td></tr>
<tr><td width="200">MD_Typical_Systolic_BP</td><td width="200">149</td><td width="200">2011-11-14</td></tr>
<tr><td width="200">Potassium</td><td width="200">4.5</td><td width="200">2006-1-2</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.4</td><td width="200">2006-1-2</td></tr>
<tr><td width="200">MD_Typical_Diastolic_BP</td><td width="200">93</td><td width="200">2011-11-14</td></tr>
<tr><td width="200">Proteinuria</td><td width="200">2+</td><td width="200">2006-1-2</td></tr>
</table>
<p><b>Medications:</b> lisinopril(10.0) hydrochlorothiazide(12.5) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Hypertension</td>
<td width="200">2005-01-02 00:00:00.0</td>
<td width="200"> 401.9()</td></tr>
<tr><td width="200">Renal_Insufficiency</td>
<td width="200">2005-01-02 00:00:00.0</td>
<td width="200"> 584.9()</td></tr>
<tr><td width="200">Renal disease</td>
<td width="200">2005-01-02 00:00:00.0</td>
<td width="200"> 584.9()</td></tr>
<tr><td width="200">Bronchospastic_Disease</td>
<td width="200">2005-01-02 00:00:00.0</td>
<td width="200"> 493.00()</td></tr>
<tr><td width="200">Hypertensive_Without_Comorbidities_That_Indicate_Non_Diuretics</td>
<td width="200"></td>
<td width="200"> Hypertension[presence of diagnosis of hypertension && absence of myocardial infarction && absence of diabetes mellitus && absence of heart failure && CKD by eGFR or ICD9 codes]()</td></tr>
<tr><td width="200">HTN without comorbidities and K+>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension[presence of HTN without comorbidities && Potassium(4.5/2006-1-2)]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Age(83.0/2008-6-4) && Sex(Male)]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(83.0/2008-6-4)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">2006-01-02 00:00:00.0</td>
<td width="200"> Proteinuria()
</table><p>
<hr>
</body></html>
